November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 15, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 9, 2022
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for Persons Aged 18 Years and Older
If EUA is granted, the Novavax COVID-19 vaccine would be the first protein-based COVID-19 vaccine available in the US.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 2, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 1, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 31, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
CDC Greenlights COVID-19 Booster for Children Aged 5 to 11 Years
The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
FDA Authorizes Pfizer-BioNTech COVID-19 Booster for Children Aged 5 to 11 Years
Children aged 5 to 11 years can receive a single dose booster shot 5 months after completing a primary 2-dose series of the Pfizer COVID-19 vaccine, FDA says.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
Shingrix: Who Needs It and Who Doesn't?
A 55-year-old healthy man has a rash on his back that is diagnosed as shingles. He has never received any shingles vaccine–is he eligible now? Plus 3 more patient scenarios.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022